Daptomycin-Resistant Enterococcus faecalis Diverts the Antibiotic Molecule from the Division Septum and Remodels Cell Membrane Phospholipids by Tran, Truc T. et al.
Daptomycin-Resistant Enterococcus faecalis Diverts the Antibiotic
Molecule from the Division Septum and Remodels Cell Membrane
Phospholipids
Truc T. Tran,a,b Diana Panesso,a,c Nagendra N. Mishra,d Eugenia Mileykovskaya,e Ziqianq Guan,f Jose M. Munita,a,g Jinnethe Reyes,a,c
Lorena Diaz,a,c George M. Weinstock,h Barbara E. Murray,a,i Yousif Shamoo,j,k William Dowhan,e Arnold S. Bayer,d,l Cesar A. Ariasa,c,i
Division of Infectious Diseases, Department of Internal Medicine, University of Texas Medical School at Houston, Houston, Texas, USAa; University of Houston, College of
Pharmacy, Houston, Texas, USAb; Molecular Genetics and Antimicrobial Resistance Unit, Universidad El Bosque, Bogota, Colombiac; Los Angeles Biomedical Research
Institute at Harbor-University of California Los Angeles Medical Center, Torrance, California, USAd; Department of Biochemistry and Molecular Biology, University of Texas
Medical School at Houston, Houston, Texas, USAe; Department of Biochemistry, Duke University Medical Center, Durham, North Carolina, USAf; Clinica Alemana de
Santiago and Universidad del Desarrollo, Santiago, Chileg; The Genome Institute, Washington University, St. Louis, Missouri, USAh; Department of Microbiology and
Molecular Genetics, University of Texas Medical School at Houston, Texas, USAi; Department of Biochemistry and Cell Biology, Rice University, Houston, Texas, USAj;
Department of Ecology and Evolutionary Biology, Rice University, Houston, Texas, USAk; David Geffen School of Medicine, University of California Los Angeles, Los
Angeles, California, USAl
ABSTRACT Treatment of multidrug-resistant enterococci has become a challenging clinical problem in hospitals around the
world due to the lack of reliable therapeutic options. Daptomycin (DAP), a cell membrane-targeting cationic antimicrobial lipo-
peptide, is the only antibiotic with in vitro bactericidal activity against vancomycin-resistant enterococci (VRE). However, the
clinical use of DAP against VRE is threatened by emergence of resistance during therapy, but the mechanisms leading to DAP
resistance are not fully understood. The mechanism of action of DAP involves interactions with the cell membrane in a calcium-
dependent manner, mainly at the level of the bacterial septum. Previously, we demonstrated that development of DAP resistance
in vancomycin-resistant Enterococcus faecalis is associated with mutations in genes encoding proteins with two main functions,
(i) control of the cell envelope stress response to antibiotics and antimicrobial peptides (LiaFSR system) and (ii) cell membrane
phospholipid metabolism (glycerophosphoryl diester phosphodiesterase and cardiolipin synthase). In this work, we show that
these VRE can resist DAP-elicited cell membrane damage by diverting the antibiotic away from its principal target (division sep-
tum) to other distinct cell membrane regions. DAP septal diversion by DAP-resistant E. faecalis is mediated by initial redistribu-
tion of cell membrane cardiolipin-rich microdomains associated with a single amino acid deletion within the transmembrane
protein LiaF (a member of a three-component regulatory system [LiaFSR] involved in cell envelope homeostasis). Full expres-
sion of DAP resistance requires additional mutations in enzymes (glycerophosphoryl diester phosphodiesterase and cardiolipin
synthase) that alter cell membrane phospholipid content. Our findings describe a novel mechanism of bacterial resistance to
cationic antimicrobial peptides.
IMPORTANCE The emergence of antibiotic resistance in bacterial pathogens is a threat to public health. Understanding the
mechanisms of resistance is of crucial importance to develop new strategies to combat multidrug-resistant microorganisms.
Vancomycin-resistant enterococci (VRE) are one of the most recalcitrant hospital-associated pathogens against which new ther-
apies are urgently needed. Daptomycin (DAP) is a calcium-decorated antimicrobial lipopeptide whose target is the bacterial cell
membrane. A current paradigm suggests that Gram-positive bacteria become resistant to cationic antimicrobial peptides via an
electrostatic repulsion of the antibiotic molecule from amore positively charged cell surface. In this work, we provide evidence
that VRE use a novel strategy to avoid DAP-elicited killing. Instead of “repelling” the antibiotic from the cell surface, VRE di-
verts the antibiotic molecule from the septum and “traps” it in distinct membrane regions. We provide genetic and biochemical
bases responsible for the mechanism of resistance and disclose new targets for potential antimicrobial development.
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The emergence of antibiotic resistance in health care-associatedpathogens is recognized as a major public health threat by the
World Health Organization (1). Vancomycin-resistant entero-
cocci (VRE) are prime examples of such multidrug-resistant or-
ganisms, against which new therapies are urgently needed (2).
Daptomycin (DAP) is a cyclic antimicrobial lipopeptide that has
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become a key frontline drug against VRE due to its potent in vitro
bactericidal activity. However, an important emerging clinical
problem is the development of DAP resistance during therapy (3,
4). DAP is heavily calcium complexed, an event which is abso-
lutely required for its antimicrobial effect becoming a de facto
cationic antimicrobial peptide (5). Recent data using fluorescence
microscopy in a Bacillus subtilismodel (6) indicate that the mech-
anism of action of DAP involves insertion of the antibiotic mole-
cule into the bacterial membrane in a calcium-dependentmanner
with a strong preference for interactions with the bacterial divi-
sion septum. Binding of the antibiotic produces membrane dis-
tortions that alter the morphology of the cell and recruit proteins
essential for cell division. The defects in cell membrane and cell
wall synthesis cause damages in cell integrity that lead to cell death
(6). Additionally, a crucial step in the mechanism of DAP-
mediated disruption of the cellmembrane appears to be the ability
of the antibiotic to oligomerize within the cell membrane, a phe-
nomenon that seems to be dependent on the presence of the neg-
atively charged phospholipid phosphatidylglycerol (PG) (5).
Although the mechanisms of DAP resistance have not been
fully elucidated, a correlation with evolution of a more relatively
positive surface charge has been observed in Staphylococcus aureus
(7–9). Electrostatic “repulsion” between relatively positively
charged cell surfaces and the calcium-DAP molecule complex is
believed to prevent initial interaction of DAP with the cell mem-
brane. Our initial genomic studies in a pair of clinical strains of
vancomycin-resistant Enterococcus faecalis recovered from the
bloodstream of a patient before and after DAP therapy indicated
that themechanism of resistance was associatedwithmutations in
two groups of genes. The first group of genes, liaFSR, encodes a
three-component regulatory system that is involved in cell enve-
lope homeostasis (10). Using an allelic replacement strategy, we
showed that deletion of isoleucine in position 177 of the putative
LiaF (lipid II-interacting-antibiotic protein) was sufficient to de-
crease DAP susceptibility (although still below the clinical break-
point) and led to DAP tolerance, abolishing the in vitro bacteri-
cidal activity of the antibiotic (11). Supporting the important role
of the LiaFSR system in development of DAP resistance, we found
that mutations in liaFSR were commonly observed in DAP-
resistant isolates of Enterococcus faecium (12, 13). A second group
of genes that seem to be involved in DAP resistance in enterococci
are ones encoding enzymes catalyzing reactions implicated in cell
membrane phospholipid metabolism (glycerophosphoryl diester
phosphodiesterase [GdpD] and cardiolipin synthase [Cls]) (12).
Indeed, we previously showed that in vivo development of DAP
resistance in enterococci is associated with important changes in
cell membrane phospholipid composition (14).Moreover, an im-
portant decrease in PG plus a surprising increase in negatively
charged phospholipid content (but not in positively charged spe-
cies as previously described in S. aureus [7, 9]) was observed in
DAP-resistant derivatives of both E. faecalis and E. faecium (14)
isolated from patients after DAP therapy, suggesting that a more
positive surface charge was not the main mediator of DAP resis-
tance in enterococci.
In this study, we demonstrate that the emergence of DAP non-
susceptibility in vancomycin-resistant E. faecalis is associated with
an initial cell membrane cardiolipin microdomain redistribution
caused by an amino acid deletion in LiaF that diverts the antibiotic
away from the division septum, a critical and vital structure for cell
survival. Themechanism is completed by changes in phospholipid
content brought about by alterations in enzymes involved in
phospholipidmetabolism. Our work offers novel insights into the
mechanisms of bacterial resistance against the attack by antimi-
crobial peptides and provides potential new targets for antimicro-
bial development.
RESULTS
Daptomycin resistance is associated with exclusion of BDP-
DAP from thedivision septum. In order to understand themech-
anism of enterococcal daptomycin (DAP) resistance, we used a
previously described clinically derived pair of E. faecalis strains, a
vancomycin-resistant DAP-susceptible (Daps) strain and a DAP-
resistant (Dapr) strain recovered from the bloodstream of a pa-
tient before and after DAP therapy (S613 and R712, respectively
[Table 1]) (12). We initially examined the binding of DAP to the
cell membrane of the Daps clinical strain, S613, versus its Dapr
variant, R712. We used boron-dipyrromethene (BODIPY)-
labeled DAP (BDP-DAP), a fluorescent derivative of DAP that
retains antimicrobial activity (MICs of 8 and 32 g/ml for strain
S613 and R712, respectively) (Table 1), to visualize DAP interac-
TABLE 1 Daptomycin-susceptible and -resistant Enterococcus faecalis strains and derivatives
Enterococcus faecalis strain
MIC (g/ml) of DAP
MIC (g/ml) of
DAP-BDPb
Predicted amino acid change
MHa BHIa TSBa Clsc LiaFd GdpDe
S613 0.5 3 2 8 None None None
R712 8 64 64 32 Deletion of Lys
at position 61
Deletion of Ile
at position 177
Deletion of Ile
at position 170
S613liaF177 3 16 16 16 None Deletion of Ile
at position 177
None
S613gdpD170 0.75 3 2 8 None None Deletion of Ile
at position 170
S613liaF177gdpD170 3 24 16 16 None Deletion of Ile
at position 177
Deletion of Ile
at position 170
S613liaF177gdpD170cls61 6 64 64 32 Deletion of Lys
at position 61
Deletion of Ile
at position 177
Deletion of Ile
at position 170
a The MIC of daptomycin was determined by the use of Etest (bioMérieux) on the indicated medium.
b The MIC of BODIPY-labeled daptomycin (BDP-DAP) was determined by broth microdilution.
c Cls, cardiolipin synthase.
d LiaF, lipid II-interacting-antibiotic protein.
e GdpD, glycerophosphoryl diester phosphodiesterase.
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tions with the cell membrane. Figure 1a and b show that at subin-
hibitory concentrations,multiple foci of BDP-DAPwere bound to
the S613 cell membrane and were distributed throughout the cell
(“peppering” pattern) but sparing the division septum. At con-
centrations at and above the MIC, BDP-DAP decorated the
E. faecalis S613 cell envelope in a homogeneous pattern, with a
clear preference for the division septum (Fig. 1c to e). Indeed, ca.
85% of cells in a microscopic field displayed a linear fluorescence
pattern at the septa (108 cells examined, BDP-DAP concentration
of 16g/ml) (see Fig. S2 in the supplemental material). The bind-
ing pattern of BDP-DAP toDapr strain R712 was similar to that of
strain S613 at low concentrations (Fig. 1f and g). Moreover, we
were able to observe consistent binding of BDP-DAP to E. faecalis
R712 at all concentrations tested (Fig. 1f to j).However, at increas-
ingly higher BDP-DAP concentrations, R712 continued to exhibit
the “peppering” pattern. Notably, this pattern excluded the mid-
points of the cells where the main septal structures are localized
(Fig. 1h to j). Even at 16 and 32 g/ml, only a small proportion of
R712 cells exhibited septal staining with BDP-DAP compared to
S613 cells (20% [n 104] and 49% [n 110], respectively; P
0.0001) (Fig. S2). To further confirm that septal exclusion of BDP-
DAP from septa is critical in the mechanism of resistance, we
quantitated the fluorescence intensity in S613 and R712 cells
treated with increasing concentrations of BDP-DAP and normal-
ized to protein contents of the samples. No differences in fluores-
cent intensities between S613 and R712 cells were observed at any
of the BDP-DAP concentrations tested (2 to 32 g/ml) (all P 
0.05) (Fig. S3), suggesting that the total amount of bound antibi-
otic was similar in S613 and R712 cells. These data suggest that
exclusion of DAP from themain septal structures and diversion of
the antibiotic to other sites of the cell membrane mediate, at least
in part, DAP resistance in E. faecalis R712.
DiversionofBDP-DAPaway fromsepta ismediatedbyamu-
tation in liaF.Our previous genomic studies comparingE. faecalis
S613 to R712 indicated that DAP resistance was associated with
the following amino acid changes: (i) deletion of Ile at position
177 of LiaF (LiaF177), amember of a three-component regulatory
system (LiaFSR) involved in cell envelope homeostasis, (ii) dele-
tion of Ile at position 170 of GdpD (GdpD170), a putative glyc-
erophosphoryl diester phosphodiesterase that is likely involved in
hydrolyzing deacylated phospholipids (PLs), and (iii) deletion of
Lys at position 61 (Cls61) of a cardiolipin (CL) synthase (Cls)
enzyme. Using an allelic replacement strategy, we then sequen-
tially introduced the resistance-associated alleles belonging to
strain R712 into strain S613 and found that LiaF177 was a pivotal
event in development of DAP resistance (12). Indeed, introduc-
tion of the resistant liaF allele alone to Daps S613 (S613liaF177)
decreased DAP susceptibility (12). Here, we show that
S613liaF177 resulted in the exclusion of BDP-DAP from septal
structures and the “peppering pattern” at higher BDP-DAP con-
centrations (8 g/ml) than seen in S613 (4 g/ml [Fig. 2a]). At
16 g/ml, homogeneous staining of the cell surface of strain
S613liaF177 and visualization of septal DAP accumulation in a
linear pattern was evident, as seen with S613 at concentrations
8 g/ml (Fig. 2a; see Fig. S4 in the supplemental material).
We subsequently evaluated the binding pattern of BDP-DAP
in anE. faecalis S613 derivative carrying both resistance-associated
liaF and gdpD alleles fromE. faecalisR712 (S613liaF177gdpD170). As
shown in Fig. 2b, no difference in the pattern of BDP-DAP stain-
ing in strain S613liaF177gdpD170 compared to S613liaF177 was
noted, suggesting that the contribution of the GdpD alteration to
diversion ofDAP from the septumwasminimal. This is consistent
with our analysis of S613gdpD170, a derivative of S613 carrying
GdpD170, whose pattern of BDP-DAP binding was identical to
FIG 1 BODIPY-labeled daptomycin (BDP-DAP) staining of representative E. faecalis S613 (DAP-susceptible) (a to e) and R712 (DAP-resistant) (f to j) cells at
increasing concentrations of the fluorescent antibiotic. The images within each panel show bacterial cells captured by fluorescence (top image) and phase-
contrastmicroscopy (bottom image) (bars, 1m). (a and b) InE. faecalis S613, binding of the antibiotic in a “peppering” pattern is observed only at subinhibitory
concentrations of BDP-DAP. (c to e) At higher BDP-DAP concentrations, saturation of the surface is observed with staining of the division septum (white
arrows). (f to j) In E. faecalis R712, the “peppering” staining pattern and binding of the fluorescent antibiotic is observed at all concentrations without
visualization of septa. Additional images selected from different microscopic fields are shown in Fig. S2 in the supplemental material.
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that of S613 (data not shown). We next created a derivative of
S613 carrying all three of the resistance-associated alleles
(S613liaF177gdpD170cls61) and found that S613liaF177gdpD170cls61 ex-
cludedBDP-DAP from septal regions and also displayed the “pep-
pering pattern” at even higher BDP-DAP concentrations (up to
16g/ml), similar to R712 (Fig. 2c; see Fig. S4 in the supplemental
material). Thus, our findings indicate that DAP resistance in-
volves antibiotic diversion from the septum, initially mediated by
a mutation in liaF and ultimately completed by concomitant mu-
tations of other enzymes involved in PL metabolism (i.e., GdpD
and Cls). Of note, we were unable to introduce the mutated cls
allele alone in S613, S613liaF177, or S613gdpD170 (after multiple
attempts), suggesting that the isolated Lys61 deletion in the puta-
tive Cls enzyme may be deleterious unless other changes in cell
membrane homeostasis brought about simultaneously by LiaF
and GdpD have occurred.
DAP resistance involves redistribution of cardiolipin mi-
crodomains away from the division septum. The hydrophobic
fluorescent dye 10-N-nonyl-acridine orange (NAO) has been
used previously to visualize CL-enriched domains in Escherichia
coli (15, 16) and B. subtilis (17, 18). The association of NAO with
CL (but not other PLs) induces a green-to-red shift in its fluores-
cence emission attributed to the ability of CL (harboring four
chains and a small head group) to make microdomains (arrays)
within the cell membrane (19, 20). This configuration provides
NAO with enough space to form arrays of parallel stacks between
the CL arrays (15, 19). As shown in Fig. 3a, visualization of Daps
E. faecalis S613 stained with NAO (500 nm) revealed CL-rich do-
mains during early stationary phase of growth. These microdo-
mains were visualized as intense linear staining at the site of the
bacterial septum and as polar spots (Fig. 3a), in agreement with
previous data generated in E. coli and B. subtilis (15–18). The
NAO-stained domains were also visualized under red fluores-
cence (see Fig. S5 in the supplemental material), indicating that
the microdomains consist of CL arrays. Additionally, NAO
(500 nm) did not affect the growth of E. faecalis S613. Important
changes in CL domain distribution were observed in E. faecalis
R712 compared to S613 (Fig. 3b), featuring markedly reduced
linear NAO fluorescence at sites of cell division (i.e., linear septal
fluorescence was observed in only 37% of R712 cells [n  65],
compared to 82% of S613 cells [n 56]; P 0.001). Instead, we
observed intense spots of NAOfluorescence (without a linear pat-
tern) with some staining localized at potential sites of cell division
(Fig. 3b and Fig. S6); these observations are consistent with the
notion that CL domain redistribution is a major mediator of DAP
resistance. Using transmission electron microscopy (TEM), we
previously showed that R712 (Dapr) harbors a plethora of aber-
rant septal structures (12). Here, also using TEM, we were able to
determine that separation of individual R712 cells was infre-
quently observed in R712, compared to S613. Indeed, R712 had a
significantly higher number ofmulticell aggregates (4 cells) than
parental S613 (57 versus 16 in 100 cells; P 0.0001) (Fig. S7). This
is consistent with alterations in the ability of these enterococcal
cells to fully divide and separate, in association with DAP resis-
tance. Thus, our data suggest that redistribution of CL arrays se-
verely affects cell division machinery. In agreement with this hy-
pothesis, anionic PLs have been proposed to mediate the
organization of cell division proteins at specific sites of the cell
membrane (CM) (21).
Figure 3c and Fig. S6 in the supplemental material show that
LiaF177 was sufficient to alter the distribution of CL microdo-
mains, since NAO staining of strain S613liaF177 was similar to
FIG 2 BODIPY-labeled DAP (BDP-DAP) staining of representative cells from E. faecalis S613 derivatives at increasing concentrations of the fluorescent
antibiotic. The images for each BDP-DAP concentration (from 2 to 32 g/ml) and strain show bacterial cells captured by fluorescence (top image) and
phase-contrast (bottom image) microscopy (bars, 1 m). (a) E. faecalis S613liaF177 is a derivative of strain S613 carrying a mutated liaF belonging to E. faecalis
R712 (daptomycin resistant). (b) S613liaF177gdpD170 is a derivative of S613 carrying both liaF and gdpD alleles from strain R712. (c) S613liaF177gdpD170cls61 carries
mutated liaF, gdpD, and cls alleles from R712. Introduction of the three mutated alleles prevents BDP-DAP interaction with the septum up to concentrations of
16 g/ml of BDP-DAP. Additional images selected from different microscopic fields are shown in Fig. S3 in the supplemental material. Arrows indicate
visualization of septum in a linear pattern.
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that of strain R712, with most cells lacking clear polar spots and
exhibiting altered staining at the sites of cell division. Consistent
with the lack of effect of the gdpDmutation onDAP resistance (see
above), we were not able to find any substantial changes in CL
microdomain distribution in strain S613gdpD170 versus strain
S613 (Fig. 3d and Fig. S6). Moreover, the pattern of NAO staining
of S613liaF177gdpD170 and S613liaF177gdpD170cls61 was similar to
that of S613liaF177 (Fig. 3e and f), indicating that the single
LiaF177 deletion was largely responsible for CL-enriched mi-
crodomain redistribution, thus establishing a link between the
LiaFSR system and changes in cell membrane PL distribution. Of
interest, the LiaFSR system of B. subtilis has been shown to medi-
ate cell envelope responses to antimicrobial peptide attack (22). In
order to quantitate the fluorescence differences between septa and
nonseptal NAO-stained domains in DAP-resistant R712, we cal-
culated the relative ratio of fluorescent intensity between these
sites. The relative ratio of fluorescent intensity between NAO-
stained domains versus septa was about 3:1, suggesting that CL-
enriched domains are concentrated away from the septum.
Cls and GdpDmediate changes in phospholipid content as-
sociatedwithDAPresistance. In order to quantitatively assess the
effects of the above genemutations on PL content, we determined
PL content of the cell membranes of E. faecalis S613 and deriva-
tives, as described previously (Table 2). In our earlier work, we
showed that E. faecalis strain S613 contains a large cadre of cell
membrane PL species, including several amino-containing,
FIG 3 Staining of representative cells from E. faecalis S613 (DAP susceptible), R712 (DAP resistant), and S613 derivatives with 10-N-nonyl-acridine orange
(NAO) at 500 nM revealing cardiolipin-rich domains in the cell membrane. The top images in panels show bacterial cells captured with a fluorescentmicroscope
(bars, 1 m). The bottom images in panels are phase-contrast images of the same bacterial cells. (a and d) In E. faecalis S613 and S613gdpD170, CL-enriched
domains are visualized at the poles and division septa. (b) CL-enriched domain redistribution is observed in DAP-resistant E. faecalis R712. (c) Introduction of
amutated liaF allele from strain R712 into strain S613was sufficient to alter the distribution of CL domains. (e and f) Introduction ofmutated gdpD and cls alleles
to S613liaF177 did not produce additional alterations in the distribution of CL-rich domains. Additional images selected from different microscopic fields are
shown in Fig. S5 in the supplemental material.
TABLE 2 Cell membrane phospholipid composition and asymmetry of Enterococcus faecalis S613 and derivatives
Strain
Cell membrane PL composition (mean % SD)a
Positively charged PLb
Total ACPc
Negatively charged PLd
I-LPG O-LPG PG CL GP-DGDAG PA NegPL
S613 6.81 2.66 6.52 1.09 19.51 4.99 20.76 0.11 44.0 3.99 5.07 1.05 4.13 0.01 6.54 0.06
S613liaF177gdpD170cls61 5.48 1.09 10.24 1.45 27.14 2.62 13.22 1.65 30.85 1.30 9.58 2.05 9.27 0.10 9.94 0.33
S613liaF177gdpD170 5.58 2.44 7.36 0.62 22.63 2.96 17.95 0.86 39.42 3.26 6.77 0.10 5.52 0.40 7.71 0.85
S613gdpD170 6.34 0.79 7.56 0.42 21.63 0.07 18.09 0.81 40.11 1.88 6.35 0.77 5.40 1.03 8.42 1.79
S613liaF177 6.09 0.25 6.83 2.19 19.90 1.64 19.95 2.11 40.74 2.38 6.96 1.12 4.72 0.50 7.72 1.23
a Values that are statistically significantly different (P 0.05) from the values for strain S613 are shown in boldface type. PL, phospholipid.
b LPG, lysyl-phosphatidylglycerol; I-LPG, LPG in the inner leaflet of the cell membrane; O-LPG, LPG in the outer leaflet of the cell membrane. The amount of phospholipid
flipping is determined by the difference between LPG content in the inner and outer leaflets of the cell membrane.
c ACP, amino-containing phospholipid. The amount of total ACP includes O-LPG, I-LPG, and two additional ACPs whose identity has not been established.
d Major anionic (negatively charged) phospholipid species isolated from the membrane of E. faecalis strains. PG, phosphatidylglycerol; CL, cardiolipin; GP-DGDAG,
glycerolphospho-diglycodiacylglycerol; PA, phosphatidic acid; NegPL, a negatively charged phospholipid species whose structure has not been determined.
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positively charged species, as well as the negatively charged PLs
such as PG, CL, phosphatidic acid, and glycerolphospho-
diglycodiacylglycerol (GP-DPDAG) (14). As shown in Table 2,
LiaF177, which reduces the DAP susceptibility of strain S613 and
is linked to changes in CL-enriched domain distribution, did not
affect actual PL content of S613 cell membranes. Similarly, no
significant changes in cellmembrane PL contentwere identified in
the double mutant S613liaF177gdpD170 compared to S613, despite
the fact that DAP MICs increased (Table 2). However, when the
liaF mutation was accompanied by changes in both gdpD and cls
(i.e., the triple mutant, S613liaF177gdpD170cls61), significant altera-
tions in cell membrane PL content were observed versus S613
including, most notably, the following: (i) a decrease in PG (ca.
40%) and CL; (ii) a compensatory increase in other negatively
charged PL species; and (iii) an increase in overall amino-
containing PLs, with substantially more “flipping” of lysyl-
phosphatidylglycerol (L-PG) to the outer leaflet of the CM as seen
by significant changes in the amount of amino-containing PLs in
the inner versus outer CM leaflet (Table 2). These findings suggest
that Cls61 (in the background of LiaF177 and GdpD170) is re-
sponsible for additional changes in cell membrane PL composi-
tion and asymmetry that augment and fully complete the DAP
resistance phenotype in E. faecalis. Moreover, in order to support
our findings that CL-enriched microdomain redistribution is the
main mediator of DAP resistance and is not related to global
changes in membrane structure, we stained E. faecalis S613 and
derivatives with the vital nonspecific stain FM 4-64 (23, 24) which
has been used to visualize a variety of bacterial membranes, in-
cluding E. coli and B. subtilis. FM 4-64 is a non-specific lipophilic
fluorescent dye (23, 24). As shown in Fig. S8 in the supplemental
material, the membranes of S613 cells stained homogeneously
with FM4-64, and the relative intensity of FM4-64 fluorescence at
the septal membranes was double that of other regions of the cells,
as described previously for B. subtilis (18, 24). The FM 4-64 stain-
ing patterns of strains S613liaF177 and S613liaF177gdpD170
(which exhibited changes in CL-enriched microdomain redis-
tribution) were similar to that of S613, indicating that CL redis-
tribution was not associated with global structural changes of the
cell membrane. Conversely, heterogeneous staining of FM 4-64
was observed in R712 (wild-type DAP-resistant strain) and
S613liaF177gdpD170cls61 (which exhibits changes in PL content). In-
deed, intense nonseptal fluorescence spots were observed in the
latter strains (Fig. S8), suggesting that changes in phospholipid
content (but not distribution) can affect the overall membrane
structure.
DISCUSSION
Cationic antimicrobial peptides are important effectors of the in-
nate host immune response system against bacterial infections
(25, 26), and such peptides are currently used as antibiotics in
clinical practice (e.g., DAP). Understanding the molecular mech-
anisms of cationic antimicrobial peptide action, as well as resis-
tance, is likely to offer new insights into bacterial cell membrane
homeostasis and thus the possibility of discovering new targets for
antimicrobial development. Using BDP-DAP, Pogliano et al. (6)
provided novel insights into the mechanism of DAP action in
B. subtilis. Indeed, interaction of DAPwith the cell membrane and
localization of BDP-DAP to the division septum appeared to be a
crucial event in the mechanism of bacterial killing by the antibi-
otic. Moreover, the same authors provided compelling evidence
that proteins involved in cell division are recruited to areas where
DAP interacts with the cell membrane, a phenomenon that is
likely to affect cell division, as previously reported (12, 27). An-
other important aspect of DAP’s mechanism of action appears to
be its oligomerization (which seems to occur in the outer leaflet of
the cell membrane), a phenomenon that is dependent on the pres-
ence of the phospholipid PG (6, 28, 29). Using lipid vesicles and
bacterial membranes from B. subtilis, Muraih et al. (5, 29) showed
that DAP molecules interact with one another to form oligomers
on liposomal and bacterial membranes.More importantly, DAP’s
ability to oligomerize is driven by stoichiometric interactions with
PG (5, 29). Previous data originating from studies performedwith
pairs of clinical strains of DAP-susceptible and DAP-resistant
S. aureus and laboratory isolates of B. subtilis (7, 22, 28) suggested
that the mechanism of DAP and antimicrobial peptide resistance
involves “repulsion” of the antibiotic molecule from the cell sur-
face by changing the overall electrical charge of the cell envelope
(becoming more positively charged) and preventing the binding
of the antibiotic molecule with its principal target, the cell mem-
brane. In S. aureus, several avenues have been postulated to con-
tribute to increased cell surface charge, including an increased
amount of positively charged amino-containing phospholipids in
the outer leaflet of the cell membrane (e.g., positively charged
L-PG) mediated by the MprF enzyme (9) and enhanced alanyla-
tion of lipoteichoic acids by theDlt proteins (30, 31). Nonetheless,
non-DAP-susceptible strains that do not appear to have changes
in cell surface charge have also been reported (32).
Our data indicate that vancomycin-resistant E. faecalis, unlike
S. aureus andB. subtilis, utilizes a distinctmechanism to overcome
the attack by calcium-decorated DAP. Using BDP-DAP, we eval-
uated the accumulation of the antibiotic in the cell envelope of a
pair of clinical strains of E. faecalis, a DAP-susceptible strain
(S613) and a DAP-resistant strain (R712). To our surprise, BDP-
DAP was not repelled from the cell surface of DAP-resistant
E. faecalis R712 (even at low concentrations), indicating that the
mechanismof resistance is not dependent on repulsion of cationic
calcium-DAP complexes from the cell envelope as previously pro-
posed (7–9, 28). Furthermore, we provide evidence that the
amount of bound BDP-DAP is similar between R712 versus S613
at all concentrations tested, suggesting that the amount of DAP
binding is not the critical determinant of resistance but the pattern
of binding to vital structures (e.g., division septum). Our data also
suggest that the mechanism of resistance relies on diversion of the
antimicrobial peptide from the septum and provide further evi-
dence that interactions of DAP with the septal structures are cru-
cial for its antimicrobial activity. Our results also indicate that
saturation of the division septum by the antimicrobial peptide
molecule is concentration dependent and occurs only at concen-
trations of the antibiotic at or above the MIC, as has been shown
previously (6), consistent with clinical observations that higher
doses than those approved for staphylococci may have clinical
benefit against enterococci (33–35).
In order to understand the biochemical basis for DAP septal
diversion, we developed a NAO staining-based technique of en-
terococcal cells. NAO interacts with CL-enriched microdomains
in the cell membrane that can be visualized by fluorescence mi-
croscopy. Using NAO staining, it has been shown in E. coli and
B. subtilis that CL-enriched domains are localized at the division
septum and cell poles (15–18). Moreover, CL and other anionic
PLs have been shown to be important for the division machinery
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(21). NAO staining of E. faecalis S613 (DAP susceptible) revealed
CL-enriched domains localized at the septum and poles. How-
ever, a striking change in CL-enriched microdomain distribution
was observed in the DAP-resistant derivative R712 in which the
CL-enriched arrayswere redistributed away from the division sep-
tum. This phenomenon was confirmed by calculating the relative
fluorescence intensities between septa andNAO-stained domains,
strongly suggesting that diversion of DAP from the septum is
likely to be mediated by changes in CL localization (and possibly
other anionic PLs). Moreover, we were able to show that a single
substitution in LiaF (deletion of Ile at position 177 of the putative
protein) was sufficient to affect the distribution of CL domains
without altering cell membrane PL composition. Taken together,
our data suggest that the LiaFSR system, which is predicted to
regulate the cell envelope response to antibiotics and antimicro-
bial peptides, is likely to mediate changes in the cell membrane by
altering PL distribution (but not content). It is also tempting to
speculate that changes in localization of PLs may also affect the
distribution of lipoteichoic acids and transmembrane proteins,
including those involved in cell wall homeostasis, affecting cell
division. Indeed, CL has been shown to affect the function of
transmembrane transporters (36, 37). Furthermore, using the vi-
tal stain FM 4-64, we also provide evidence that CL-enriched mi-
crodomain distribution is not associated with global structural
changes in the cell membrane.
Although PL redistribution was important as an initial step
toward resistance, it was not sufficient to confer clinical resistance.
Indeed, introduction of substitutions in enzymes involved in PL
metabolism (GdpD and Cls) were necessary to confer high levels
of resistance to DAP. Interestingly, introduction of Cls61 into
E. faecalis S613 harboring the mutated liaF and gdpD alleles pro-
duced a striking change in PL content and DAP resistance similar
to that of E. faecalisR712, suggesting that the biochemical changes
in cell membrane composition brought about by this mutation
increased the ability of the enterococcal cell to resist the attack by
the antimicrobial peptide. Of note, we recently showed that a dif-
ferent substitution in Cls (R218Q) (38), which is also associated
withDAP resistance, increased the catalytic activity of the enzyme,
suggesting that changes in Cls are likely to confer a “gain-in-
function” phenotype, as has been previously shown withMprF. It
is also important to note that Cls61 could be introduced only
when the LiaF and GdpD substitutions were also present, suggest-
ing that enzymatic changes in Cls may be compatible only under
specific cell membrane conditions and that changes in enzyme
activitymay be deleterious unless compensatory events also occur.
On the basis of our results, a cogent model for the mechanism
ofDAP resistance has emerged. InDAP-susceptible E. faecalis, cell
membrane architecture is preserved, with PG and CL constituting
the main PL species. In the absence of activation of the LiaFSR
system (wild-type LiaF), CL-enriched domains are localized at
sites of cell membrane curvature, namely the septum and poles
(similar to what has been shown in E. coli and B. subtilis). In the
presence of low concentrations of positively charged calcium-
bound DAP (sub-MIC), the antibiotic binds to the cell mem-
brane, initially sparing the septum. When the concentration of
DAP increases to or above the MIC, the antibiotic accumulates at
the septum, producing alterations in cell membrane architecture
and impairment of cell division, leading to cell death. In DAP-
resistant E. faecalis, activation of the LiaSR two-component regu-
latory system results in redistribution of CL-enrichedmicroarrays
away from the septum. Subsequent changes in PL synthesis en-
zymes (such as GdpD and Cls) alter the PL composition which,
among other effects, drastically reduces PG content in the cell
membrane. Due to these changes, calcium-complexed DAP can-
not effectively bind to the septumand is diverted to cellmembrane
sites that, while deficient in PG, are rich in other negatively
charged PLs. Consequently, DAP is diverted to those sites but
cannot oligomerize therein, failing to fully distort cell membrane
architecture and homeostasis. Using this sophisticated strategy,
enterococci are able to survive the DAP attack. Our findings sug-
gest a new paradigm in the mechanism of resistance to antimicro-
bial peptides; future studies should concentrate on dissecting the
LiaFSR response in enterococci with the intention of using this
information to develop novel antimicrobial agents that may im-
pair the cell membrane response to daptomycin and other antibi-
otics.
MATERIALS AND METHODS
Bacterial strains and growth conditions. Bacterial strains and their phe-
notypes are listed in Table 1. Enterococcus faecalis S613 is a vancomycin-
resistant clinical bloodstream isolate recovered from a patient with recur-
rent bacteremia in 2005 (3). E. faecalis R712 is a derivative of S613,
recovered from blood from the same patient after ca. 14 days of dapto-
mycin (DAP) and amikacin therapy (3). Strains S613liaF177 and
S613liaF177gdpD170 are laboratory derivatives of S613 into which the liaF
and gdpD alleles from strain R712 were introduced and have been de-
scribed previously (12). Strain S613liaF177gdpD170cls61, generated here,
harbors allelic replacements of liaF, gdpD. and cls (see below). Unless
otherwise noted, enterococci were cultured in brain heart infusion (BHI)
broth at 37°C with gentle agitation. DAP and boron-dipyrromethene
(BODIPY) fluorescence (FL)-labeled DAP (BDP-DAP) were provided by
Cubist Pharmaceuticals (Lexington, MA). DAP MICs were determined
on Mueller-Hinton (MH) and BHI agars by Etest (bioMérieux). DAP
MICs in trypticase soy broth (TSB) were determined by broth microdilu-
tion supplemented with Ca2 (50 mg/liter). Results were interpreted
based on the breakpoints recommended by the Clinical and Laboratory
Standards Institute (CLSI) (39) onMH agar. BDP-DAPMICs were deter-
mined in Luria-Bertani (LB) broth (supplemented with Ca2 [50 mg/
liter]) by microdilution with increasing concentrations of the fluorescent
antibiotic.
Mutant construction and genetic manipulations. In order to
create an E. faecalis S613 derivative harboring the mutated liaF, gdpD,
and cls alleles from E. faecalis R712, we used the p-chloro-phenylalanine
(p-Chl-Phe) sensitivity counterselection system (PheS*) (40) with
plasmid pHOU3 (which carries the chloramphenicol acetyltransferase
gene conferring resistance to chloramphenicol) as described previously
(12). Briefly, primers 5=-ATAAGAATGCGGCCGCGATGCAGCTGT-
TGCACGTTT (forward) and 5=-GGAATTCCGCGTATCCCGCCA-
ATAGCC (reverse) ~500 bp upstream and downstream, respectively, of
the codon encoding position 61 of Cls were used for PCR amplifications
using the genomic DNA of strain R712 as the template. PCR products
were cloned into pHOU3 using NotI and EcoRI. The plasmid constructs
were electroporated into E. faecalis CK111 and subsequently delivered to
E. faecalis S613liaF177gdpD170 by conjugation (12, 41). First, recombina-
tion integrants were selected on plates containing chloramphenicol
(15 g/ml) and vancomycin (32 g/ml). In order to obtain the desired
replacement, first-event integrants were subsequently grown on p-chloro-
phenylalanine, and colonies were tested by replica plating in the presence
and absence of chloramphenicol (12). Chloramphenicol-susceptible mu-
tants were characterized by pulsed-field gel electrophoresis, and the open
reading frames of the three genes (liaF, gdpD, and cls) were sequenced in
their entirety in both directions. Growth curves of the mutant
(S613liaF177gdpD170cls61) were performed in BHI and compared to the
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growth curves of strains S613, S613liaF177, S613liaF177gdpD177 and R712
as shown in Fig. S1 in the supplemental material.
BDP-DAP staining of E. faecalis strains. BODIPY FL-labeled dapto-
mycin (BDP-DAP) (Cubist Pharmaceuticals) is a fluorescent derivative of
daptomycin that retains antimicrobial activity. By using fluorescence mi-
croscopy, bacterial cells can be imaged, and the sites of accumulation of
BDP-DAP in the cell membrane can be determined as previously de-
scribed (6, 22, 28). Organisms were grown to exponential phase in LB
broth at 37°C with gentle shaking. One hundred microliters of each sam-
ple was incubated with BDP-DAP at increasing concentrations (2 g/ml
to 32g/ml) in LB (supplemented with Ca2 [50 mg/liter]) for 10 min in
darkness. Excess unincorporated BDP-DAP was removed by washing the
cells in LB broth three times, and the cells were immobilized on a coverslip
treated with poly-L-lysine (Sigma-Aldrich). Bacterial cells were viewed
with an Olympus IX71 microscope equipped with PlanApo N 100 ob-
jective. Fluorescence was observed using a standard fluorescein isothio-
cyanate (FITC) filter set (excitation at 490 nm and emission at 528 nm).
Data acquisition was performed by SlideBook 5.0 software and processed
using Adobe Photoshop CS5. A minimum of two independent experi-
ments was performed for each strain on different days. In order to esti-
mate the amount of BDP-DAP bound to E. faecalis strain S613 versus
strain R712, we quantitated the fluorescence intensity in S613 and R712
cells treated with increasing concentrations of BDP-DAP and normalized
to protein contents of the samples. S613 and R712 cells were treated with
BDP-DAP as described above, and fluorescence was measured following
excitation at 488 nm and emission at 510 nm. Protein extraction from the
cells was performed by previously described methods (42). Protein con-
centrations were estimated using the bicinchoninic acid (BCA) protein
assay kit (Thermo Scientific) according to the manufacturer’s instruc-
tions.
Staining of E. faecalis strains using NAO and FM 4-64.Visualization
of cardiolipin (CL)-rich domainswas performedusing the fluorescent dye
10-N-nonyl acridine orange (NAO). NAO has been shown to bind pref-
erentially to CL-enriched arrays in the cell membrane, allowing visualiza-
tion of CL-enriched domains in the cell membrane (19). Association of
NAO with CL molecules results in a green-to-red shift in fluorescence
(20). For microscopic examination, cells were grown in TSB to exponen-
tial phase (A600 of ~0.3). NAO (Molecular Probes) was added to growth
medium to a final concentration of 500 nM, which did not inhibit growth
of E. faecalis. Samples were allowed to stain for 3.5 h at 37°C in darkness
with gentle shaking. After incubation, E. faecalis cells were washed three
times with 0.9% saline and immediately immobilized on a coverslip
treated with poly-L-lysine (Sigma-Aldrich). Fluorescent images were cap-
tured by anOlympus IX71microscope with a PlanApoN 100 objective.
The focus was set under phase-contrast conditions and then shifted to
light emission conditions to capture fluorescent images and minimize
photobleaching. The exposure time was 500ms. Green fluorescence from
NAO was detected using a standard fluorescein isothiocyanate (FITC)
filter (excitation at 490 nm and emission at 528 nm). Image acquisition
was performed using the SlideBook 5.0 software package. At least three
independent sets of experiments were performed for each strain on dif-
ferent days. Captured images were processed using Adobe Photoshop
CS5. In a single experiment, the viability of cells was confirmed by placing
coverslips with NAO-stained bacteria on BHI agar and incubating the
coverslips at 37°C overnight. All strains grew, indicating that NAO was
not toxic to enterococci and that the images were taken while the cells
were alive. Additionally, green-to-red fluorescence shift in the images was
examined using the Nikon A1 confocal laser microscope equipped with
100 Plan-Apo/1.4-numerical-aperture (NA) oil objective. Fluorescence
was viewed using the PicoQuant imaging system. Excitation was at
490 nm and emission was at either 528 or 617 nm at exposure times of 500
ms. Fluorescent areas identified at both wavelengths indicate a green-to-
red shift, a property exhibited by NAO when bound to cardiolipin (see
Fig. S4 in the supplemental material). Images of individual cells were used
to calculate the ratio of NAOfluorescence intensity at the division septum
versus nonseptal NAO-stained domains in strain R712 (43, 44). Intensity
was quantitated by acquiring pixel-to-area values in the areas of interest
(ImageJ software). Three septal areas versus nonseptal domains were av-
eraged prior to calculation of the fluorescence intensity ratio. FM 4-64
(Molecular Probes) was added to a final concentration of 1g/ml to a cell
culture in TSB that was harvested in stationary growth phase. After incu-
bation at 37°C for 30min, the cells were fixed on slides coated with a layer
of 0.8% agarose gel in water. Fluorescent images were viewed using an
Olympus IX71 microscope with a PlanApo N 100 objective. Red fluo-
rescence was detected using a standard tetramethyl rhodamine isothio-
cyanate (TRITC) filter (excitation at 541 nm and emission at 617 nm).
Image acquisition was performed using the SlideBook 5.0 software pack-
age. At least two independent experiments were performed on different
days for each strain. Images were processed with Adobe Photoshop CS5.
Transmission electron microscopy. Transmission electron micros-
copy (TEM)was used to assess ultrastructural characteristics of the pair of
E. faecalis strains, strains S613 and R712, using standard methods as pre-
viously described (12). Chaining (4 cells) was evaluated in both S613
and R712 by counting100 cells of each isolate from different fields.
Cell membrane phospholipid composition and asymmetry. Phos-
pholipids (PLs) were extracted from enterococcal isolates using a meth-
odology described before (45, 46). Briefly, extraction of PLs was per-
formed on enterococcal isolates grown in TSB for 18 h (late stationary
phase). The PLs were separated using two-dimensional thin-layer chro-
matography (TLC) using Silica Gel 60 F254 high-performance (HP) TLC
plates (Merck). A first dimension of chloroformmethanol25% am-
monium hydroxide (65:25:6, by volume) and a second dimension of
chloroform-water-methanol-glacial acetic acid-acetone (45:4:8:9:16, by
volume) in the vertical and horizontal orientation, respectively, were used
for the separation of the PLs (46). The identification of TLC PL spots was
made in comparison to control two-dimensional (2D) TLC plates of
known PL standards, which were purchased from Avanti Polar Lipids
(Alabaster, AL). For quantitative analysis, individual PLs fromTLC plates
were digested with 0.3 ml of 70% perchloric acid (0.3 ml) at 180°C for 3 h
and then quantified spectrophotometrically at A660 (46). Experiments
were performed at least three times on separate days. Data were reported
as the mean ( standard deviation [SD]).
Outer cell membrane (CM) lysyl-phosphatidylglycerol (LPG) distri-
bution was determined using fluorescamine analysis, since this fluoro-
phore specifically labels only surface-exposed amino-PLs in the outer CM
leaflet as described previously (7, 46). These experiments were performed
in parallel with the PL extraction and analyses described above. PL spots
on the TLC plate were confirmed by exposure to iodine vapors and spray-
ing with CuSO4 (100 mg/ml) containing 8% phosphoric acid (vol/vol)
and heated at 180°C (47). LPG in the inner leaflet of the cell membrane
(I-LPG) (positively charged), and other amino-containing PLs were visu-
alized by ninhydrin staining.
LC/ESI-MS/MS analysis.Major lipids separated on the 2D-TLC plate
were scraped off, extracted with chloroform, and confirmed by normal-
phase liquid chromatography-electrospray ionization-tandemmass spec-
trometry (LC/ESI-MS/MS) analysis as described before (14). Briefly,
normal-phase LC was performed on an Agilent 1200 Quaternary LC sys-
tem equipped with an Ascentis Silica high-performance liquid chroma-
tography (HPLC) column (5 m; 250 by 2.1 mm; Sigma-Aldrich, St.
Louis, MO). Themobile phases were chloroform-methanol-aqueous am-
monium hydroxide (800:195:5, vol/vol) (mobile phase A solvent),
chloroform-methanol-water-aqueous ammonium hydroxide (600:340:
50:5, vol/vol) (mobile phase B solvent), and chloroform-methanol-water-
aqueous ammonium hydroxide (450:450:95:5, vol/vol) (mobile phase C
solvent). The elution program consisted of the following: 100% mobile
phaseA solventwas held isocratically for 2min and then linearly increased
to 100% mobile phase B solvent over 14 min and held at 100% mobile
phase B solvent for 11 min. The LC gradient was then changed to 100%
mobile phase C solvent over 3 min, held at 100% C for 3 min, finally
returned to 100%mobile phase A solvent over 0.5 min, and held at 100%
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phase A solvent for 5 min. The total LC flow rate was 300 l/min. To
achieve optimum ESI efficiency, a postcolumn splitter was used to divert
~10% of the LC effluent into the mass spectrometer, a QSTAR XL quad-
rupole time-of-flight tandem mass spectrometer (Applied Biosystems,
Foster City, CA). Instrumental settings for negative ion electrospray (ESI)
andMS/MS analysis of lipid species were as follows: ion spray voltage (IS)
4,500 V; curtain gas (CUR) 20 lb/in2; gas source–I (GSI) 20 lb/
in2; declustering potential (DP)55 V; and focusing potential (FP)
150 V. The MS/MS analysis used nitrogen as the collision for the gas.
Data analysis was performed using Analyst QS software (Applied Biosys-
tems, Foster City, CA).
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